ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3

Current endocrine therapy for prostate cancer (PCa) mainly inhibits androgen/androgen receptor (AR) signaling. However, due to increased intratumoural androgen synthesis and AR variation, PCa progresses to castration-resistant prostate cancer (CRPC), which ultimately becomes resistant to endocrine t...

全面介紹

Na minha lista:
書目詳細資料
發表在:Theranostics
Main Authors: Zhou, Lijie, Song, Zhengshuai, Hu, Junyi, Liu, Lilong, Hou, Yaxin, Zhang, Xiaoping, Yang, Xiong, Chen, Ke
格式: Artigo
語言:Inglês
出版: Ivyspring International Publisher 2021
主題:
Research Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738848/
https://ncbi.nlm.nih.gov/pubmed/33391508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.49384
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍